Evidence map›Paper›PMID 20145083›Full record

ArticleAntimicrobial agents and chemotherapy2010

In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.

Emilia Cantón, Ana Espinel-Ingroff, Javier Pemán, Lucas del Castillo

Abstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Antimicrobial agents and chemotherapy · 2019
    Article
  3. Article
  4. Candida parapsilosis: from Genes to the Bedside.Clinical microbiology reviews · 2019
    Review
  5. Methodologies forMicrobial cell (Graz, Austria) · 2018
    Review
  6. Article
  7. Caspofungin-Non-SusceptibleIranian journal of public health · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antifungal lock therapy.Antimicrobial agents and chemotherapy · 2013
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Evaluation of matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry for identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emilia CantónUnidad de Microbiología Experimental, Centro de Investigación, Hospital Universitario La Fe, Valencia. Spain. canton_emi@gva.es
Ana Espinel-Ingroff
Javier Pemán
Lucas del Castillo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anidulafungin, micafungin, and caspofungin in vitro activities against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis were evaluated by MICs and time-kill methods. All echinocandins showed lower MICs (mean MICs, 0.05 to 0.71 mg/liter) and the highest killing rates (-0.06 to -0.05 CFU/ml/h) for C. metapsilosis and C. orthopsilosis rather than for C. parapsilosis (mean MICs, 0.59 to 1.68 mg/liter). Micafungin and anidulafungin killing rates were greater than those determined for caspofungin. None of the echinocandins had fungicidal activity against C. parapsilosis.

Indexed as

AnidulafunginAntifungal AgentsCandidaCaspofunginEchinocandinsIn Vitro TechniquesLipopeptidesMicafunginMicrobial Sensitivity TestsMicrobiological TechniquesTime FactorsAnidulafunginAntifungal AgentsCaspofunginEchinocandinsLipopeptidesMicafungin

Identifiers

PMID20145083
PMCPMC2863676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.